MedTrace Logo

Belgian Mitraclip Registry

NCT02506387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2025-07-18

No results posted yet for this study

Summary

The primary objective of the registry is to investigate and follow all patients treated with the MitraClip System in Belgium. This information is intended to contribute to decision making with regards to MitraClip therapy selection in patients with mitral regurgitation: (a) by establishing the clinical value of the MitraClip therapy in the continuum of care; and (b) by providing practical information that will allow physicians to make therapeutic decisions, assist hospitals to make purchasing decisions, and assist insurers/government in making coverage decisions.

In addition national data will be shared with European registries in order to increase the knowledge about the efficacy of this new technique.

Conditions

  • Mitral Valve Insufficiency

Interventions

DEVICE

mitraclip

The decision to implant mitraclip is not part of this observational study but is made by the heart-team.

Sponsors & Collaborators

  • Universiteit Antwerpen

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2023-01-31
Completion
2024-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02506387 on ClinicalTrials.gov